Nal-IRI (liposomal irinotecan)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Nal-IRI (liposomal irinotecan), covering 2025-03-13 to 2025-07-11. Get the full timeline:
Most recent: Clinical Trial Update: NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers [Phase 1]